Gilles Salles, MD, PhD
Lymphoma Specialist & Cellular Therapist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Hodgkin and non-Hodgkin Lymphomas: Follicular Lymphoma, Diffuse Large B Cell Lymphoma, MALT and Marginal Zone Lymphoma
- Immunotherapy for Lymphoma
About Me
- Chief, Lymphoma Service, Steven A. Greenberg Chair
I am a medical oncologist devoted to caring for people with hematologic cancers, including lymphoma and chronic lymphocytic leukemia. While I have broad experience in all subtypes of lymphoma, I have a particular expertise in treating diffuse large B-cell, follicular, and other B-cell lymphoma.
After 35 years of practice, I continue to be impressed by patients as they courageously fight these diseases. I value the exchanges I have with my patients and their families and take the time to answer their questions and explain the latest advances available to help manage their illness. These include immunotherapy, targeted therapy, chemotherapy and radiation therapy.
Read more
As a member of MSK’s Lymphoma Service Disease Management Team, I work closely with colleagues in other disciplines to formulate the best possible treatment plan that meets the specific needs of each patient.
I see patients in Manhattan at MSK Koch, which offers nearly every aspect of outpatient cancer care across many specialties, so most patients can get all their treatments in one place. The state-of-the-art facility was designed to help restore patients’ health and well-being.
My passion for hematology oncology emerged during my residency. I was drawn to the dual challenge of bringing faster scientific progress to people suffering from cancer and providing medical care for those patients over the entire course of their disease. As my career became deeply focused on lymphoma, I have been fortunate to see major improvements in diagnosis and treatment achieved over the last three decades.
It has been gratifying to be personally involved in some of these advances. For example, in recent years, I contributed to the development of immunotherapies (such as monoclonal antibodies and CAR T cell therapy) for people with B cell lymphoma.
I continue to be dedicated to various aspects of clinical research, including large studies that aim to establish the best standards of care and trials that are evaluating the safety and effectiveness of new treatments that may ultimately lead to new drug approvals. When our research staff determines that a patient is eligible to enroll in one of our clinical studies, we offer that individual the opportunity to participate as part of their care plan.
I moved to New York from Lyon, France with my wife in 2020 to join MSK as Chief of the Lymphoma Service. She and I enjoy listening to live music in our spare time and we are excited about getting into the jazz music scene in the city. It’s such a pleasure when we come across talented musicians during our walks through Central Park.
A lymphoma specialist is a doctor with special training in diagnosing and treating lymphoma.
A cellular therapy specialist is a doctor with special training in using cell therapies to treat health conditions such as cancer. Therapies can include chimeric antigen receptor (CAR) T cell therapy.
My Specialties
- Hodgkin and non-Hodgkin Lymphomas: Follicular Lymphoma, Diffuse Large B Cell Lymphoma, MALT and Marginal Zone Lymphoma
- Immunotherapy for Lymphoma
Education
- MD, University Claude Bernard, Lyon France
- PhD, University Claude Bernard, Lyon France
Residencies
- Internal Medicine, Lyon University Hospitals (1984-1989)
Awards and Honors
- Jose Carreras Award, European Hematology Association (2020)
- Steven Greenberg Chair at Memorial Sloan Kettering Cancer Center (2021)
Fellowships
- Hemato-Oncology, Lyon University Hospital - clinical
- Harvard Medical School - research
Board Certifications
- Internal Medicine, French Board of Physicians (1989)
- Oncology, French Board of Physicians (1992)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Salles sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Salles
- A Phase 1 Study of JNJ-80948543 Immunotherapy in People with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
- A Phase 3 Study of Epcoritamab and R-CHOP Versus R-CHOP Alone in People With Newly Diagnosed Lymphoma
- A Phase 3 Study of Glofitamab With Standard Treatment in People With Previously Untreated Large B-Cell Lymphoma
- A Phase IB/III Study of Lenalidomide and Rituximab plus Tazemetostat or Placebo in Patients with Recurrent or Persistent Follicular Lymphoma
Read more
- Clinical Trials Co-Investigated by Dr. Salles
- A Phase 1 Study of ABBV-319 in People With B-Cell Cancers
- A Phase 1 Study of BMS-986458 Alone and With Rituximab in People With Non-Hodgkin Lymphoma
- A Phase 1/2 Study of IPH6501, a Novel Immunotherapy, in People With Non-Hodgkin Lymphoma
- A Phase 2 Study of Outpatient Epcoritamab Therapy in People With Persistent Lymphoma
- A Phase 3 Study of Epcoritamab Plus Standard Treatment Compared to Standard Treatment Alone in People With Follicular Lymphoma
- A Phase II Study of Mosunetuzumab as Initial Chemotherapy-Free Treatment for Follicular Lymphoma
- A Pilot Study of 131-I Apamistamab and CAR T-Cell Therapy in People with Recurrent or Persistent Leukemia or Lymphoma
- A Pilot Study of Glofitamab and Lenalidomide in People With Previously Treated Mantle Cell Lymphoma
- A Study of CA-4948 in Patients with Recurrent or Persistent Non-Hodgkin Lymphoma
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Gilles Salles discloses the following relationships and financial interests:
-
AbbVie
Professional Services and Activities -
Aptitude Health
Professional Services and Activities -
BeiGene USA, Inc.
Professional Services and Activities -
Bristol-Myers Squibb
Professional Services and Activities -
Celgene
Professional Services and Activities -
Curio Science LLC
Professional Services and Activities -
Debiopharm
Professional Services and Activities -
Everest Clinical Research Corporation
Professional Services and Activities -
Fondazione Ferrata Storti
Professional Services and Activities -
GenMab
Professional Services and Activities -
Incyte
Professional Services and Activities -
Innate Pharma
Professional Services and Activities -
Ipsen Pharma
Professional Services and Activities -
Janssen Global Services, LLC
Professional Services and Activities -
Janssen Korea Ltd.
Professional Services and Activities
-
Kite Pharmaceuticals
Professional Services and Activities -
Medscape
Professional Services and Activities -
Merck & Co Inc.
Professional Services and Activities -
MJH Life Sciences
Professional Services and Activities -
ModeX Therapeutics Inc.
Professional Services and Activities -
Novartis
Professional Services and Activities -
Nurix Therapeutics, Inc.
Professional Services and Activities -
Orna Therapeutics, Inc.
Professional Services and Activities -
Owkin, Inc.
Equity -
Practice Point Communications, LLC
Professional Services and Activities -
Research to Practice
Professional Services and Activities -
Roche
Professional Services and Activities -
Scientific Education Support Ltd.
Professional Services and Activities -
Treeline Biosciences, Inc.
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].